share_log

Femasys (NASDAQ:FEMY) Stock Price Up 8.5%

Femasys (NASDAQ:FEMY) Stock Price Up 8.5%

Femasys（纳斯达克股票代码：FEMY）股价上涨8.5％
Defense World ·  2022/12/17 02:11

Femasys Inc. (NASDAQ:FEMY – Get Rating) shares rose 8.5% during mid-day trading on Friday . The stock traded as high as $1.12 and last traded at $1.12. Approximately 2,795 shares changed hands during mid-day trading, a decline of 98% from the average daily volume of 168,899 shares. The stock had previously closed at $1.03.

纳斯达克(Femasys Inc.)股价周五午盘上涨8.5%。该股一度涨至1.12美元，最后报1.12美元。午盘交易中，约有2,795股易手，较168,899股的日均成交量下降了98%。该股此前收盘价为1.03美元。

Wall Street Analyst Weigh In

华尔街分析师也加入进来

Several equities research analysts recently commented on the stock. HC Wainwright cut their price target on shares of Femasys from $8.00 to $5.00 and set a "buy" rating for the company in a report on Thursday, October 20th. Chardan Capital cut their price target on shares of Femasys from $15.00 to $12.00 and set a "buy" rating for the company in a report on Friday, November 11th.

几位股票研究分析师最近对该股发表了评论。在10月20日星期四的一份报告中，HC Wainwright将Femasys的股票目标价从8.00美元下调至5.00美元，并将该公司的评级定为“买入”。Chardan Capital在11月11日星期五的一份报告中将Femasys的股票目标价从15.00美元下调至12.00美元，并为该公司设定了“买入”评级。

Get
到达
Femasys
费马西斯
alerts:
警报：

Femasys Stock Performance

Femasys股票表现

The company has a market cap of $13.23 million, a PE ratio of -1.42 and a beta of -0.31. The firm's fifty day moving average is $1.20 and its 200 day moving average is $1.59. The company has a current ratio of 9.56, a quick ratio of 9.37 and a debt-to-equity ratio of 0.01.

该公司市值为1323万美元，市盈率为-1.42，贝塔系数为-0.31。该公司的50日移动均线切入位为1.20美元，200日移动均线切入位为1.59美元。该公司的流动比率为9.56，速动比率为9.37，债务权益比率为0.01。

Institutional Investors Weigh In On Femasys

机构投资者看好Femasys

A number of large investors have recently modified their holdings of FEMY. Vanguard Group Inc. purchased a new stake in shares of Femasys during the first quarter worth $269,000. CM Management LLC grew its holdings in shares of Femasys by 33.3% during the second quarter. CM Management LLC now owns 300,000 shares of the company's stock worth $723,000 after buying an additional 75,000 shares in the last quarter. UBS Group AG grew its holdings in shares of Femasys by 6,394.8% during the first quarter. UBS Group AG now owns 66,702 shares of the company's stock worth $151,000 after buying an additional 65,675 shares in the last quarter. Clear Creek Financial Management LLC grew its holdings in shares of Femasys by 74.7% during the second quarter. Clear Creek Financial Management LLC now owns 150,801 shares of the company's stock worth $363,000 after buying an additional 64,500 shares in the last quarter. Finally, Royal Bank of Canada grew its holdings in shares of Femasys by 2,381.2% during the first quarter. Royal Bank of Canada now owns 55,158 shares of the company's stock worth $125,000 after buying an additional 52,935 shares in the last quarter. Hedge funds and other institutional investors own 6.87% of the company's stock.
一些大型投资者最近修改了对Femy的持股。先锋集团在第一季度购买了价值26.9万美元的Femasys新股。CM Management LLC在第二季度增持了33.3%的Femasys股票。CM Management LLC在上个季度又购买了7.5万股后，现在拥有30万股该公司股票，价值72.3万美元。今年第一季度，瑞银集团对Femasys股票的持有量增加了6,394.8%。瑞银集团(UBS Group AG)现在持有66,702股该公司股票，价值15.1万美元，上个季度又购买了65,675股。Clear Creek Financial Management LLC在第二季度增持了74.7%的Femasys股票。Clear Creek Financial Management LLC现在持有150,801股该公司股票，价值36.3万美元，上个季度又购买了64,500股。最后，加拿大皇家银行在第一季度增持了2,381.2%的Femasys股票。加拿大皇家银行在上个季度又购买了52,935股，现在持有55,158股该公司股票，价值125,000美元。对冲基金和其他机构投资者持有该公司6.87%的股份。

Femasys Company Profile

Femasys公司简介

(Get Rating)

(获取评级)

Femasys Inc, a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing.

Femasys Inc是一家生物医药公司，专注于美国的女性保健市场。该公司开发了永久性节育解决方案，如FemBloc和FemChec；FemaSeed，一种人工授精解决方案；FemCerv，一种用于宫颈刮宫的活检设备；以及FemEMB，一种用于子宫内膜采样以支持子宫癌检测测试的候选产品。

Featured Articles

专题文章

  • Get a free copy of the StockNews.com research report on Femasys (FEMY)
  • Which Two Bluechip Tech Companies Have Raised Their Guidance?
  • Should You Worry About Elon Musk Selling His Tesla Shares?
  • Can Tractor Supply Stock Surge Past Cup-With-Handle Buy Point?
  • This is no Time to Buy Lennar but the Time is Coming
  • Game-Changing News For Mullen Automotive
  • 免费获取StockNews.com关于Femasys(Femy)的研究报告
  • 哪两家蓝筹科技公司提高了他们的指引？
  • 你应该担心埃隆·马斯克出售他持有的特斯拉股票吗？
  • 拖拉机库存能否突破杯柄收购点？
  • 现在不是购买Lennar的时候，但时机即将到来
  • 马伦汽车公司改变游戏规则的消息

Receive News & Ratings for Femasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Femasys and related companies with MarketBeat.com's FREE daily email newsletter.

接受Femasys Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Femasys和相关公司的最新新闻和分析师评级的每日简要摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发